Jorge Cortes, MD on Phase 2 PACE Trial: What is the real rate? #ASCO2020 #ASCO

Jorge Cortes, MD on Phase 2 PACE Trial: What is the real rate? #ASCO2020 #ASCO

User Photo
Cancer-News

3 months
16 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Jorge Cortes, MD of Georgia Cancer Center at Augusta University discusses AOEs in the ponatinib phase II PACE trial (NCT01207440) in patients with Ph+ leukemia.

Read here: https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.7550?af=R&

Up Next Autoplay